Pirinixic Acid

Pirinixic Acid

SCHEMBL6563348

Cc1cccc(Nc2cc(Cl)nc(SCC(=O)[O-])n2)c1C.[Na+]

nearest known ligand 0.80

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Pirinixic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PPARG known ✓ P37231 13/20 0.80
ALOX5 known ✓ P09917 3/20 0.57
PPARA Q07869 16/20 0.80
RXRA P19793 10/20 0.80
RXRB P28702 9/20 0.80
RXRG P48443 7/20 0.80
PPARD Q03181 5/20 0.80
KDM4E B2RXH2 1/20 0.80
MEN1 O00255 1/20 0.80
ABCC4 O15439 1/20 0.80
ABCB11 O95342 1/20 0.80
ALDH1A1 P00352 1/20 0.80
CYP3A4 P08684 1/20 0.80
CYP2D6 P10635 1/20 0.80
HPGD P15428 1/20 0.80
ALOX15 P16050 1/20 0.80
KMT2A Q03164 1/20 0.80
SMN1; SMN2 Q16637 1/20 0.80
PTGES O14684 4/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pirinixic Acid SCHEMBL29370056 0.89 PPARA (1.00) PPARAPPARGRXRARXRBRXRG
Pirinixic Acid SCHEMBL293161 0.89 PPARA (1.00) PPARAPPARGRXRARXRBRXRG
SCHEMBL11833234 0.88 PPARA (0.82) PPARAPPARGRXRARXRBRXRG
SCHEMBL6563962 0.86 PPARA (0.78) PPARAPPARGRXRARXRBRXRG
SCHEMBL11483023 0.85 PPARA (0.77) PPARAPPARGRXRARXRBRXRG
SCHEMBL6565495 0.85 PPARA (0.77) PPARAPPARGRXRARXRBRXRG
SCHEMBL11492690 0.84 PPARA (0.76) PPARAPPARGRXRARXRBRXRG
SCHEMBL11483773 0.84 PPARA (0.76) PPARAPPARGRXRARXRBRXRG
SCHEMBL11491689 0.83 PPARA (0.74) PPARAPPARGRXRARXRBRXRG
SCHEMBL11484264 0.83 PPARA (0.74) PPARAPPARGRXRARXRBRXRG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1399426-A2 COMPOUNDS, COMPOSITIONS AND METHODS FOR MODULATING BETA-AMYLOID PRODUCTION Active Pass Pharmaceuticals, Inc. (CA) 2004-03-24 EP disclosed
WO-2002100836-A2 COMPOUNDS, COMPOSITIONS AND METHODS FOR MODULATING BETA-AMYLOID PRODUCTION ACTIVE PASS PHARMACEUTICALS, INC. (CA) 2002-12-19 WO disclosed
US-3940394-A ANTILIPEMIC SANTILLI ARTHUR A 1976-02-24 US disclosed